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ABSTACT
Objective 
To assess the manifestations of pain in PD (Parkinson’s disease ) patients versus healthy controls.
Methods 
Data on pain was collected from 127 patients and an equivalent number of controls using two self-report
questionnaires: the Brief Pain Inventory (BPI) and a custom-made questionnaire focusing on specific details
not covered by the former. Additional analysis was conducted within the patient group only to analyze the
potential effects of factors relating to PD on the various measure of interest relating to pain.
Results 
Parkinson disease patients  had lower odds of  experiencing pain in both arms (ExpB=0.061, p<0.001),
greater probability of demonstrating pain in both legs (ExpB=2.409, p=0.024), and an increase difficulty in
localizing pain (ExpB=2.958, p=0.030).  There was no relationship between duration of  pain (F=12.414,
p=0.001) or arthritis (ExpB=0.724, p=0.309) and pain in PD. The likelihood of experiencing nagging pain
(ExpB=3.533, p=0.028), but not other forms, was much more strongly associated with PD patients than
normal controls. When all other types of pain were controlled for, pain in PD is more likely associated with
akathesic pain (ExpB=9.046, p<0.001).
Conclusion 
There are major differences between pain in PD patients and pain in normal controls, which could have
implications on the pathophysiology and adequate management of pain in different populations.
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INTRODUCTION
Description and classification of pain in PD
While Parkinson’s disease (PD) classically presents with tremor, rigidity, akinesia/bradykinesia and postural
instability, patients often experience a much broader scope of symptomology [4, 27]. Later stages of this
disease may manifest as dementia, depression, or psychosis [22]. Furthermore, over 90% of PD patients
may experience  non-motor  symptoms,  including  pain  [19].  Several  studies,  such  as  the  case  study by
Djaldetti et al., have demonstrated that pain is much more frequent in patients with PD than in the healthy
population [9]. Roughly 30-85% of patients with PD complain of experiencing pain, the large variation likely
being accounted for by varying definitions and assessment tools [2]. Pain can be classified as either primary
or secondary, the latter being more prevalent. Further classifications are achieved on the basis of  major
symptom etiologies [24].
Primary pain, or pain of central origin, is defined as pain that arises directly from the disease process itself [2,
24]. Patients may present with general discomfort or malaise. Alternatively, they may experience unexplained
sensations in unexpected locations. These may be painful, stabbing, itching, burning, aching or tingling in
character [24].
On the other hand, secondary pain arises from states that are consequent to PD [17]. The major etiologies of
secondary pain include radicular/neuropathic pain, musculoskeletal  (MSK) pain, akathisia,  pain related to
restless legs syndrome (RLS), and dystonia-related pain [24]. Radicular/neuropathic pain is due to a direct
insult  of  the  nervous  system  itself,  and  is  characterized  by  persistent  tingling,  shooting,  electrical  or
parasthetic sensation [1]. Pathology of the muscular and skeletal structures of patients with PD may lead to
MSK pain. This is a potential consequence of rigidity and akinesia, which are both common early features of
PD [16]. Akathisia is described as a psychological and physical irritability, where the patient is unable to
remain still. It is a potential side effect of prolonged exposure to typical antipsychotic medications, such as
Haloperidol, but may also be present in PD patients [24]. This is in contrast to RLS, where patients feel the
urge to move but maintain voluntary control over their muscles. Furthermore, only RLS is tied to circadian
rhythms [3]. Restless legs syndrome is diagnosed by the presence of the following four features: the urge to
move limbs,  accompanied by unpleasant sensations and feelings;  worsened by rest  and inactivity; relief
through getting-up and moving around; and urges being the worst in the evening [3]. Of all the secondary
causes of  pain,  dystonia is  the most  intense. Dystonia is a movement  disorder characterized by painful
twisting and unusual postures, which are secondary to sustained muscle contractions [15].
Management of pain in PD
Management  of  pain  in  PD  may  be  achieved  through  either  pharmacological  or  non-pharmacological
approaches, or a combination of both [2]. The classification of pain as either primary or secondary helps to
determine the ideal treatment regime. The sub-classification of secondary pain plays an additional role [24].
For  example,  the  optimal  treatment  for  MSK  pain  is  a  combination  of  MSK  examinations;
physical/occupational  therapy;  medical,  anti-inflammatory,  and  dopaminergic  therapies;  and  surgical
alternatives, such as decompressive surgery when indicated [24]. On the other hand, pain related to akathisia
is best  managed with dopaminergic therapy, opioids and benzodiazepines [24].  Thus,  safe and effective
treatment  strategies  do  exist.  However,  more  focused  research  is  needed  to  maximize  effective  pain
management in PD patients [24].
Direction of our study
Pain affects individuals both physically and psychologically, ultimately impairing their ability to perform daily
activities. Despite such a high prevalence, pain has yet to be well studied among PD patients. In our current
study, we compare the prevalence of pain and its potential causes among PD patients to a similar group of
control subjects. Among the individuals who experience pain, the reported severity, sensation, duration, and
location are also analyzed.
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MATERIALS AND METHODS
Study participants
Data was collected from 127 patients and an equivalent number of controls by a neurologist at a community-
based Parkinson’s disease and movement disorders center in 2013. Patients were diagnosed with idiopathic
PD though UK Brain Bank Criteria, and were regularly assessed three to four times a year for follow-up care
[14]. Patients ranged in age from 37 to 93 years. All patients were informed about the nature of the study and
gave their written consent for participation. The local ethics review board approved of the study.
Study methods
Two self-report questionnaires were used: the Brief Pain Inventory (BPI) and a custom-made questionnaire
focusing on specific details not covered by the former, including items specific to PD [6]. Participants were
screened based on the presence of focal or generalized body pain, such as headaches. A negative finding
would exclude the patient from our study. Participants provided information for potential causes by giving
accounts of past medical history as well as other relevant events. Medical records were available to provide
verification  and  additional  details.  The  variables  of  interest  relating  to  pain  were  compared  within  and
between the groups to identify any differences in manifestation and/or cause. Patients were asked details on
the nature of the pain experienced, such as onset, location, alleviating/exacerbating factors, quality, radiation,
severity and timing.  Additional sequelae,  such  as  tingling,  burning or  cramping were  assessed.  Further
analysis was conducted within the patient group to analyze the potential effects of factors relating to PD (side
of body affected, Hoehn and Yahr stage, UPDRS score, etc.) on the various measure of interest relating to
pain [13, 18]. Exclusion criteria included patients with atypical parkinsonism, drug-induced parkinsonism, as
well as pain due to external causes and/or cognitive dysfunction.
Statistical methods
The causes and manifestations of pain in PD patients versus healthy controls were compared and assessed
with Pearson correlations and multiple logistical regressions using SPSS version 19 (SPSS Inc., Chicago, IL,
USA). A significance level of 0.05 was used throughout all of the analyses.
RESULTS
Pain in 127 patients with PD was compared to pain in an equivalent number of  controls.  Patients were
assessed for the location of and ability to locate pain; the relationship between arthritis and duration of pain to
pain in  PD patients  versus  controls;  the likelihood of  experiencing various  qualities  of  pain;  as  well  as
differences in the specific types of pain experienced.
Firstly, it was found that patients with PD had a decreased likelihood of experiencing pain in both arms when
compared to controls (ExpB=0.061, P<0.001, Table 1). Furthermore, pain in either arm was not significantly
correlated to the presence of PD in pain patients. Conversely, the odds of experiencing pain in both legs
increased 2.4-fold in patients with PD (ExpB=2.409, P=0.024, Table 1). Interestingly, pain is almost three-
times as difficult to locate in patients with PD when compared to normal controls (ExpB=2.958, P=0.030,
Table  1).  Further  analysis  demonstrated  that  there  was  not  a  significantly  increased  propensity  of
experiencing pain in PD for patients with arthritis (ExpB=0.724, P=0.309, Table 2) or a longer duration of pain
(F=12.414, P=0.001, Table 3).
When assessed for likelihood of experiencing certain qualities of pain in PD patients versus healthy controls,
only nagging pain was reported as being significantly more likely. Indeed, there was a 3.5-times greater
probability of  experiencing nagging pain in  subjects  with  the onset  of  PD as  opposed to  those without
(ExpB=3.533,  P=0.028, Table  4).  There  was no difference in  likelihood for  aching,  dull,  tension,  sharp,
penetrating, shooting, throbbing, gnawing and numb pain. Radiating, boring, burning, stabbing and tender
pain were excluded due to low sample size. When subjects were assessed for the likelihood of experiencing
various  types of  pain in  PD versus  non-PD,  patients  with  PD were  found to  be 9-times  more  likely to
experience akathesic pain when other types of pain were held constant (ExpB=9.046, P<0.001, Table 5).
Other forms of pain include non-localized, dystonic, and neuropathic pain. When akathesic pain was not
controlled for, neuropathic pain became significant in PD patients (ExpB=2.530, P=0.018, Table 5). Further
analysis  found that  patients  with  pain  and PD had an increased chance  of  experiencing an interaction
between akathesic and neuropathic pain (ExpB=3.862, P=0.027, Table 5). A summary of the PD+ and PD-
populations that experienced certain locations, qualities, and types of pain is highlighted on Table 6.
DISCUSSION
Location of pain
Pain in PD is well recognized. Three recent reviews highlight the wide range of pain symptoms associated
with  PD  and  describe  new  ways  of  characterizing  and  classifying  nociceptive,  neuropathic  and
musculoskeletal pain of Parkinson’s disease [10, 12, 29]. Our study found that PD patients are more likely to
experience pain in both legs as compared to arms. Limb pain in the form of unilateral or bilateral shoulder
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pain, hand and leg pain has previously been described in relation to PD and a recent review summarizes
these and other locations of pain [10, 26]. Another recent study describes persistent leg pain as a distinct
entity and provides information specific to this presentation [28]. This may help explain why PD patients are
more likely to experience leg pain than arm pain.
Localization of pain
PD patients experiencing pain had greater difficulty identifying the precise location of pain when compared to
healthy individuals. This may represent a novel finding, as to our knowledge, there is no literature comparing
PD patients ability to localize pain to healthy individuals. We also found that PD patients were more likely to
report their pain as aching when compared to healthy individuals. This is in agreement with another recent
study, which found that the most common physical experience of pain in PD patients was aching [21].
Quality of pain
Our study demonstrates that patients with PD are 9-times more likely to experience akathesic pain when
compared to healthy controls. It has already been established that Parkinson’s disease is closely associated
with akathisia, as both seem to arise from the basal ganglia [25, 30]. Indeed, akathisia has been found to
occur in up to 45% of PD patients, and correlates with both the age of onset and severity of PD [7]. However,
the basis of this association remains controversial, and has been postulated as a consequence of dopamine
receptor blocking drugs, and not PD itself [21]. Another theory is that alterations in the mesocortical pathway,
which is associated with the cognitive defects of PD, may be involved in the pathophysiology of akathisia [20].
Although a clear etiology has yet to be defined, our study adds further support to the increased prevalence of
akathesic pain in patients with PD, and may provide insight for how patients can better manage their pain.
MSK comorbidities and pain in PD
The fact that patients with PD and arthritis were not more likely to experience pain than those with PD alone
removes arthritis  as a comorbidity that  may compound our  findings.  Musculoskeletal  problems are very
common in PD as well as with the general population, and an important contributor to a decreased quality of
life [31].  However,  studies on the prevalence of  arthritis  and PD are conflicting,  with some showing an
increased prevalence, and others not [8, 23]. If there is in fact a greater prevalence of MSK problems in PD
patients,  the  management  of  these  symptoms  should  not  be  neglected,  especially  in  post-deep  brain
stimulation (DBS) patients where it  is  a common complaint [11].  In addition, past studies have shown a
positive  correlation  between  MSK  problems  and  pain  in  PD  patients  [31,  32].  Despite  this  possible
association, pain in PD patients within our study population seems to have not been affected by arthritis. One
possible explanation is that the MSK pain was overpowered by a concomitant akathesic pain. Regardless of
the reason, more studies should be performed to clarify this discrepancy, and to elucidate a more definitive
relation between arthritis and pain in PD.
Strengths and weaknesses of study
Compared to studies reported in the literature, the present study had a relatively large sample size and
adopted a novel  approach to  the study of  pain in  the PD population.  This  approach,  in addition to  the
standardized assessment methods used which may limit biases, is a significant strength of this study and
was shown to be applicable to the study of PD-associated pain. Importantly, research with questionnaires
filled out by PD patients and their caregivers may more accurately reflect feelings of pain in the life of PD
patients. Excluding patients with cognitive dysfunction and dementia also helped to ensure the validity of
patient accounts throughout the interview process. Another strength was that our analysis accounted for the
effect  of  various  localizations  and  types  of  pain.  Our  study  is  not  without  limitations,  however.
Neurophysiologic examinations may have been useful to objectify the classification into pain types in some
cases (e.g. better define what is meant by “aching pain”). Secondly, the subjective nature of pain leaves
some limitations to all studies of pain in humans. Finally, our group of healthy individuals was not aged-
matched controls, thereby possibly limiting the strength of our results.
CONCLUSIONS
In  spite  of  pain  being a  common NMS in  PD,  it  continues  to  be under-reported and under treated as
demonstrated in a recent study across European centres [5]. It is thought that these symptoms may remain
undeclared to health-care professionals due to a lack of awareness by the patient that the symptoms are
linked to PD. This highlights the need for enhanced awareness and a better understanding of pain in PD by
clinicians. We therefore feel that the publication of more detailed information regarding pain phenotypes in
PD is important, as this will promote early recognition and management of PD related pain. Our long-term
goal would be to increase the chance of effective management, enabling a better quality of life for patients
affected by this debilitating disease.
Conflit d’intérêt : Aucun 
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Table  1.  Location of  and ability  to  pinpoint  pain  in  Parkinson’s  disease patients  versus healthy
controls.
Variable N B SE Wald Significance
Exp(B
)











0.000 0.061 0.016 0.231
Constant . 2.797 0.461
36.87





5.124 0.024 2.409 1.125 5.156
Constant . -0.032
0.17
8 0.032 0.859 0.969 . .




4.693 0.030 2.958 1.109 7.890
Constant . 0.014 0.168 0.007 0.933 1.014 . .
Table 2. The relationship between arthritis and pain in Parkinson’s disease patients.
















Constant . 0.294 0.206
2.02
7 0.155 1.341





t-test for Equality of Means













0 0.058 17.140 8.944
. . 1.78
3
50.474 0.081 17.140 9.615
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Table 4. Likelihood of experiencing various qualities of pain in Parkinson’s disease patients versus
normal controls. Radiating, boring, burning, stabbing and tender pain were excluded due to lack of
sample size.
Sensations of Pain N B SE Wald Significance
Exp(B
)







































































7 0.934 0.958 . .
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Table 5.  Likelihood of  experiencing various types of  pain in Parkinson’s disease patients versus
healthy controls. Pain type likelihood is assessed when all forms of pain are held constant and when
all types minus akathesic pain are controlled for. Interactions between akathesic and neuropathic
pain are also analyzed.

















2.515 0.113 0.356 0.099 1.276
Dystonic pain 67 0.283
0.37





1.940 0.164 1.800 0.787 4.114









3.269 0.071 0.662 . .










0 1.246 0.264 0.541 0.184 1.591
Dystonic pain 67 0.393
0.35





5.643 0.018 2.530 1.176 5.441
Constant . -0.147
0.21
0 0.493 0.482 0.863 . .






5.433 0.020 3.892 1.241 12.202
Constant . 0.027 0.166 0.027 0.869 1.028 . .
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Table  6.  Summary  of  the  population  that  experienced  pain  with  (PD+1)  and  without  (PD+0)
Parkinson’s disease.
Location or characteristics of pain PD+
0 1
N N
Right arm only 0 74 80
1 2 10
Left arm only 0 70 79
1 6 11
Both arms 0 5 82
1 8 8
Right leg only 0 72 84
1 4 6
Left leg only 0 70 78
1 6 12
Both legs 0 64 62
1 12 28
Aching 0 9 15
1 31 49
Throbbing 0 34 44
1 6 20
Shooting 0 34 44
1 6 20
Stabbing 0 37 49
1 3 15
Gnawing 0 33 54
1 7 10
Sharp 0 31 40
1 9 24
Tender 0 37 47
1 3 17
Burning 0 34 45
1 6 18
Exhausting 0 30 25
1 10 39
Tiring 0 24 20
1 16 44
Penetrating 0 36 46
1 4 18
Nagging 0 32 39
1 8 25
Numb 0 35 49
1 5 15
Generalized body pain 0 67 82
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1 9 8
Cramping pain 0 53 52
1 23 38
Neuropathic pain 0 63 58
1 13 32
Akathsic pain 0 71 54
1 5 36
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